Most Recent
Landmark class action filed against Victoria over botched hotel quarantine program
COVID-19 2020-08-28 7:21 pm By Alison Eveleigh

The State of Victoria has been hit with a class action for its allegedly negligent handling of its hotel quarantine program, which is believed to […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

St Basil’s hit with class action over COVID-19 outbreak
COVID-19 2020-08-21 4:21 pm By Christine Caulfield

St. Basil’s in Victoria has become the latest aged care facility to face a class action over its allegedly negligent handling of the coronavirus pandemic. […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Court approves $2.9M penalty against HealthEngine for misleading reviews
Competition & Consumer Protection 2020-08-20 1:20 pm By Miklos Bolza

A court has approved a $2.9 million penalty against medical booking platform HealthEngine after the company admitted to deleting and altering unfavourable reviews and misusing […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Class action launched against Melbourne aged care home at centre of COVID-19 outbreak
COVID-19 2020-08-18 12:22 pm By Alison Eveleigh

The son of a 92-year-old woman who died after she contracted COVID-19 at a Melbourne aged care home has brought a class action against the […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

QRx Pharma shareholders to get small slice of $7M class action settlement
Class Actions 2020-08-11 10:18 pm By Cat Fredenburgh

A former QRx Pharma director’s prediction that shareholders would not receive “anything of consequence” from a class action settlement has proven true, with only a […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Mayne Pharma faces potential class action over US antitrust case
Class Actions 2020-08-10 3:54 pm By Christine Caulfield

ASX-listed generic drug maker Mayne Pharma is facing a possible shareholder class action over disclosures related to US price-fixing allegations against the ASX-listed company. Law […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

HealthEngine urges approval of $2.9M fine, says it didn’t know altering reviews was unlawful
Competition & Consumer Protection 2020-08-10 12:05 pm By Miklos Bolza

Health booking company HealthEngine has urged the court to accept a $2.9 million penalty for deleting and altering unfavourable reviews, telling a judge that it […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

QRxPharma shareholders to learn of class action settlement one year later
Class Actions 2020-08-05 1:56 pm By Miklos Bolza

After “unavoidable delays”, shareholders will soon be notified of a settlement reached one year ago in a class action against QRxPharma, but a company director […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Further pain for AFT as court finds new Maxigesic ads misleading
Competition & Consumer Protection 2020-08-04 4:18 pm By Miklos Bolza

AFT Pharmaceuticals has suffered another blow over its Maxigesic advertisements, with a judge finding the marketing material misled consumers by claiming to provide better, faster […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Sandoz wins appeal of $26.3M infringement ruling in IP battle over Lexapro
Intellectual Property 2020-08-04 3:05 pm By Miklos Bolza

Generic drug maker Sandoz has successfully appealed a $26.3 million judgment finding it infringed a patent owned by rival H Lundbeck relating to the top-selling […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.